Product References
Levels of sex steroid hormones and their receptors in women with preeclampsia.
Reproductive biology and endocrinology : RB&E
Lan KC,Lai YJ,Cheng HH,Tsai NC,Su YT,Tsai CC,Hsu TY
Published figure using Estrogen Receptor alpha monoclonal antibody (Product # MA1-39540) in Western Blot
Tue Feb 18 00:00:00 EST 2020
Levels of sex steroid hormones and their receptors in women with preeclampsia.
Reproductive biology and endocrinology : RB&E
Lan KC,Lai YJ,Cheng HH,Tsai NC,Su YT,Tsai CC,Hsu TY
Published figure using Estrogen Receptor alpha monoclonal antibody (Product # MA1-39540) in Western Blot
Tue Feb 18 00:00:00 EST 2020
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα.
Nature
Britschgi A,Duss S,Kim S,Couto JP,Brinkhaus H,Koren S,De Silva D,Mertz KD,Kaup D,Varga Z,Voshol H,Vissieres A,Leroy C,Roloff T,Stadler MB,Scheel CH,Miraglia LJ,Orth AP,Bonamy GM,Reddy VA,Bentires-Alj M
MA139540 was used in flow cytometry and western blot to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation.
Thu Jan 26 00:00:00 EST 2017
Integrated Molecular Characterization of Uterine Carcinosarcoma.
Cancer cell
Cherniack AD,Shen H,Walter V,Stewart C,Murray BA,Bowlby R,Hu X,Ling S,Soslow RA,Broaddus RR,Zuna RE,Robertson G,Laird PW,Kucherlapati R,Mills GB,Weinstein JN,Zhang J,Akbani R,Levine DA
MA139540 was used in reverse phase protein array to characterize the molecular identity of uterine carcinosarcomas.
Mon Mar 13 00:00:00 EDT 2017
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
Nielsen TO,Jensen MB,Burugu S,Gao D,Jørgensen CL,Balslev E,Ejlertsen B
MA139540 was used in immunohistochemistry - paraffin section to investigate the interaction between breast cancer subtype and treatment using data from a breast cancer trial randomizing women to adjuvant chemotherapy
Wed Feb 15 00:00:00 EST 2017
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling.
Cell systems
Hill SM,Nesser NK,Johnson-Camacho K,Jeffress M,Johnson A,Boniface C,Spencer SE,Lu Y,Heiser LM,Lawrence Y,Pande NT,Korkola JE,Gray JW,Mills GB,Mukherjee S,Spellman PT
MA139540 was used in western blot to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches
Wed Jan 25 00:00:00 EST 2017
Profiling protein expression in circulating tumour cells using microfluidic western blotting.
Nature communications
Sinkala E,Sollier-Christen E,Renier C,Rosàs-Canyelles E,Che J,Heirich K,Duncombe TA,Vlassakis J,Yamauchi KA,Huang H,Jeffrey SS,Herr AE
MA139540 was used in western blot to describe a microfluidic western blot for an eight-plex protein panel for individual circulating tumor cells derived from estrogen receptor-positive breast cancer patients
Thu Mar 23 00:00:00 EDT 2017
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology
O'Shaughnessy J,Campone M,Brain E,Neven P,Hayes D,Bondarenko I,Griffin TW,Martin J,De Porre P,Kheoh T,Yu MK,Peng W,Johnston S
MA1-39540 was used in immunohistochemistry - paraffin section to study estrogen receptor-positive metastatic breast cancer in postmenopausal patients and abiraterone acetate, exemestane or a combination of both
Fri Jan 01 00:00:00 EST 2016
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
Breast cancer research and treatment
Matsumoto H,Thike AA,Li H,Yeong J,Koo SL,Dent RA,Tan PH,Iqbal J
MA139540 was used in immunohistochemistry to explore the relationship between tumor-infiltrating lymphocytes and the clinical outcomes of triple-negative breast cancers
Fri Apr 01 00:00:00 EDT 2016
Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel.
Journal of Cancer
Trapé AP,Liu S,Cortes AC,Ueno NT,Gonzalez-Angulo AM
MA1-39540 was used in western blot to study inhibition in hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer cells with acquired resistance to Paclitaxel by effects of CDK4/6
Fri Jun 17 00:00:00 EDT 2016
Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.
Molecular diagnosis & therapy
Petrovic N,Davidovic R,Jovanovic-Cupic S,Krajnovic M,Lukic S,Petrovic M,Roganovic J
MA139540 was used in immunohistochemistry - paraffin section to study the correlation of miR-221/222, estrogen receptor and TIMP3 in breast cancer.
Thu Dec 01 00:00:00 EST 2016
Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?
Annals of surgical oncology
Kim SY,Kim EK,Lee HS,Kim MJ,Yoon JH,Koo JS,Moon HJ
MA1-39540 was used in immunohistochemistry - paraffin section to characterize diagnosis of asymptomatic benign papilloma without atypia via ultrasonography-guided 14-gauge core needle biopsy to determine a possible subgroup to monitor by observation
Wed Jun 01 00:00:00 EDT 2016
Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility.
Oncology letters
Al-Harras MF,Houssen ME,Shaker ME,Farag K,Farouk O,Monir R,El-Mahdy R,Abo-Hashem EM
MA1-39540 was used in immunohistochemistry - paraffin section to research the association of breast cancer susceptibility and polymorphisms of glutathione S-transferase pi and toll-like receptors 2 and 9
Tue Mar 01 00:00:00 EST 2016
Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
Pathology oncology research : POR
El-Gendi SM,Mostafa MF
MA1-39540 was used in immunohistochemistry - paraffin section to elucidate the role of Runx2 during the early stages of breast cancer and metastasis
Fri Jul 01 00:00:00 EDT 2016
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models.
BMC cancer
Koussounadis A,Langdon SP,Um I,Kay C,Francis KE,Harrison DJ,Smith VA
MA1-39540 was used in immunohistochemistry - paraffin section to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression
Thu Mar 10 00:00:00 EST 2016
Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.
ESMO open
Bonneterre J,Bosq J,Jamme P,Valent A,Gilles EM,Zukiwski AA,Fuqua SA,Lange CA,O'Shaughnessy J
MA139540 was used in immunohistochemistry - paraffin section to examine the histological subnuclear morphology of active and inactive progesterone receptor in archival breast cancer samples
Tue Jan 26 00:00:00 EST 2021
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.
Journal of experimental & clinical cancer research : CR
Carbognin L,Sperduti I,Brunelli M,Marcolini L,Nortilli R,Pilotto S,Zampiva I,Merler S,Fiorio E,Filippi E,Manfrin E,Pellini F,Bonetti F,Pollini GP,Tortora G,Bria E
MA1-39540 was used in immunohistochemistry - paraffin section to identify prognostic indicators of resected early stage 'pure' and 'mixed' lobular breast cancer by using subpopulation treatment effect pattern plot (STEPP) analysis of Ki67 histology assay
Tue Mar 22 00:00:00 EDT 2016
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research
McBryan J,Fagan A,McCartan D,Bane FT,Varešlija D,Cocchiglia S,Byrne C,Bolger J,McIlroy M,Hudson L,Tibbitts P,Gaora PÓ,Hill AD,Young LS
MA1-39540 was used in immunohistochemistry - paraffin section to investigate global expression changes during metastatic disease progression
Tue Dec 01 00:00:00 EST 2015
Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family.
Journal of biomedical science
Kawai M,Nakashima A,Kamada S,Kikkawa U
MA1-39540 was used in immunohistochemistry - paraffin section to discuss methods to treat triple-negative breast cancer
Sat Jul 04 00:00:00 EDT 2015
Role of epithelial-mesenchymal transition markers in triple-negative breast cancer.
Breast cancer research and treatment
Cheung SY,Boey YJ,Koh VC,Thike AA,Lim JC,Iqbal J,Tan PH
MA1-39540 was used in immunohistochemistry - paraffin section to characterize triple-negative breast cancer and the role of epithelial-mesenchymal transition markers
Sat Aug 01 00:00:00 EDT 2015
Loss of ERβ expression in papillary thyroid carcinoma is associated with recurrence in young female.
Clinical endocrinology
Ahn HY,Kim MS,Kim MJ,Cho SY,Kim YA,Lee GH,Lee BC,Park YJ,Yi KH
MA1-39540 was used in immunohistochemistry to study the prognostic value of the immunohistochemical expression of ERbeta in young female patients with papillary thyroid carcinoma
Sun Feb 01 00:00:00 EST 2015
The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Pathology, research and practice
Kapucuoğlu N,Bozkurt KK,Başpınar Ş,Koçer M,Eroğlu HE,Akdeniz R,Akçil M
MA1-39540 was used in immunohistochemistry to evaluate the expression of CD24, CD44, CD133 and ALDH1 in invasive ductal carcinoma of the breast
Thu Oct 01 00:00:00 EDT 2015
Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture.
Nature communications
Fridriksdottir AJ,Kim J,Villadsen R,Klitgaard MC,Hopkinson BM,Petersen OW,Rønnov-Jessen L
MA1-39540 was used in immunocytochemistry to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture
Fri Nov 13 00:00:00 EST 2015
Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.
PloS one
Heskamp S,Boerman OC,Molkenboer-Kuenen JD,Wauters CA,Strobbe LJ,Mandigers CM,Bult P,Oyen WJ,van der Graaf WT,van Laarhoven HW
MA1-39540 was used in immunohistochemistry - paraffin section to determine poor outcome in breast cancer patients in regards to upregulation of IGF-1R expression in neoadjuvant therapy
Fri Apr 29 00:00:00 EDT 2016
MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases.
Molecular and clinical oncology
Mundim FG,Pasini FS,Brentani MM,Soares FA,Nonogaki S,Waitzberg AF
MA1-39540 was used in immunohistochemistry to investigate markers expressed by stromal cells in breast cancer patients.
Fri May 01 00:00:00 EDT 2015
Differential expression of lipid metabolism-related proteins in different breast cancer subtypes.
PloS one
Kim S,Lee Y,Koo JS
MA1-39540 was used in immunohistochemistry - paraffin section to characterize different breast cancer subtypes and differential expression of lipid metabolism-related proteins
Fri Jan 15 00:00:00 EST 2016
Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy.
Ecancermedicalscience
Gómez R,Ossa CA,Montoya ME,Echeverri C,Ángel G,Ascuntar J,Borrero M,Gil M,Herrera S,Gutiérrez E,Herazo F,Jiménez A,Madrid J,Reyes PA,Zuluaga L,García H
MA139540 was used in immunohistochemistry to report the demographic characteristics, recurrence pattern, and survival rate in Colombian females with breast cancer
Fri Aug 28 00:00:00 EDT 2015
Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
PloS one
Jung YY,Kim HM,Koo JS
MA1-39540 was used in immunohistochemistry - paraffin section to analyze metastatic breast cancer and the expression of lipid metabolism-related proteins
Tue May 24 00:00:00 EDT 2016
Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
Cell death & disease
Felzen V,Hiebel C,Koziollek-Drechsler I,Reißig S,Wolfrum U,Kögel D,Brandts C,Behl C,Morawe T
MA1-39540 was used in western blot to determine stress resistance to breast cancer cells and neuroblastoma by BAG3 function and estrogen receptor alpha that regulates non-canonical autophagy
Thu Jul 09 00:00:00 EDT 2015
Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma.
Oncotarget
Coelho RG,Calaça IC,Celestrini DM,Correia-Carneiro AH,Costa MM,Zancan P,Sola-Penna M
MA1-39540 was used in immunohistochemistry - paraffin section to analyze how aggressiveness and invasiveness of human breast carcinoma is correlated with hexokinase and phosphofructokinase kinase and intracellular distribution
Tue Oct 06 00:00:00 EDT 2015
T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant.
Cancer letters
Kirkegaard T,Hansen SK,Larsen SL,Reiter BE,Sørensen BS,Lykkesfeldt AE
MA1-39540 was used in western blot to study the switch from ER/HER to HER/c-Src signaling as T47D breast cancer cells acquire fulvestrant resistance
Sat Mar 01 00:00:00 EST 2014
Lack of correlation of stem cell markers in breast cancer stem cells.
British journal of cancer
Liu Y,Nenutil R,Appleyard MV,Murray K,Boylan M,Thompson AM,Coates PJ
MA1-39540 was used in immunohistochemistry - paraffin section to determine breast cancr stem cells and the lack of correlation of stem cell markers
Tue Apr 15 00:00:00 EDT 2014
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
Breast cancer research : BCR
Zhang H,Cohen AL,Krishnakumar S,Wapnir IL,Veeriah S,Deng G,Coram MA,Piskun CM,Longacre TA,Herrler M,Frimannsson DO,Telli ML,Dirbas FM,Matin AC,Dairkee SH,Larijani B,Glinsky GV,Bild AH,Jeffrey SS
MA1-39540 was used in immunohistochemistry to study the efficacy of mTOR inhibitors against xenografts of patient triple-negative breast cancer samples
Mon Apr 07 00:00:00 EDT 2014
Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: evidence for a common origin.
Histopathology
Boecker W,Stenman G,Loening T,Andersson MK,Sinn HP,Barth P,Oberhellmann F,Bos I,Berg T,Marusic Z,Samoilova V,Buchwalow I
MA1-39540 was used in immunohistochemistry to study the potential common origin of syringomatous tumor of the nipple and low-grade adenosquamous carcinoma of the breast
Tue Jul 01 00:00:00 EDT 2014
A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
Histopathology
Kommoss S,Gilks CB,Penzel R,Herpel E,Mackenzie R,Huntsman D,Schirmacher P,Anglesio M,Schmidt D,Kommoss F
MA1-39540 was used in immunohistochemistry to study the diagnostic value of testing for FOXL2 mutations in patients with suspected adult-type granulosa cell tumours of the ovary
Sat Feb 01 00:00:00 EST 2014
Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome.
Histopathology
Chan AW,Tong JH,Sung MY,Lai PB,To KF
MA1-39540 was used in immunohistochemistry to report on seven cases of EBV-associated lymphoepithelioma-like cholangiocarcinoma
Sat Nov 01 00:00:00 EDT 2014
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue.
Laboratory investigation; a journal of technical methods and pathology
Neumeister VM,Parisi F,England AM,Siddiqui S,Anagnostou V,Zarrella E,Vassilakopolou M,Bai Y,Saylor S,Sapino A,Kluger Y,Hicks DG,Bussolati G,Kwei S,Rimm DL
MA1-39540 was used in immunohistochemistry - paraffin section to establish a tissue quality index as an intrinsic control for measurement of different effects of preanalytical variables on FFPE tissue
Tue Apr 01 00:00:00 EDT 2014
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
Breast cancer research and treatment
Irshad S,Gillett C,Pinder SE,A'hern RP,Dowsett M,Ellis IO,Bartlett JM,Bliss JM,Hanby A,Johnston S,Barrett-Lee P,Ellis P,Tutt A
MA1-39540 was used in immunohistochemistry to study the predictive and prognostic value of Tau expression within the TACT trial of taxanes for adjuvant therapy of early breast cancer
Tue Apr 01 00:00:00 EDT 2014
Ovarian-cell-like cells from skin stem cells restored estradiol production and estrus cycling in ovariectomized mice.
Stem cells and development
Park BW,Pan B,Toms D,Huynh E,Byun JH,Lee YM,Shen W,Rho GJ,Li J
MA1-39540 was used in immunohistochemistry to study the restoration of estradiol production and estrus cycling in ovariectomized rats following transplantation of skin stem cell-derived ovarian cell-like cells
Tue Jul 15 00:00:00 EDT 2014
Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.
Obstetrics & gynecology science
Kim EH,Kim JY,Lee YH,Chong GO,Park JY,Hong DG
MA1-39540 was used in immunohistochemistry to study GnRH agonist-sensitive and -resistant uterine fibroids to determine if ER-alpha, PR and calponin are differentially expressed
Sat Mar 01 00:00:00 EST 2014
17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.
Oncotarget
Wright PK,Jones SB,Ardern N,Ward R,Clarke RB,Sotgia F,Lisanti MP,Landberg G,Lamb R
MA1-39540 was used in western blot to study genes that regulate vesicle formation in breast cancer
Fri May 30 00:00:00 EDT 2014
Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance.
British journal of cancer
Palmieri C,Gojis O,Rudraraju B,Stamp-Vincent C,Wilson D,Langdon S,Gourley C,Faratian D
MA1-39540 was used in immunohistochemistry to examine the expression of SRC-3 in epithelial ovarian cancers and its influence on outcome or the efficacy of treatment
Tue May 28 00:00:00 EDT 2013
Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.
Breast cancer research : BCR
Harrison H,Simões BM,Rogerson L,Howell SJ,Landberg G,Clarke RB
MA1-39540 was used in western blot to study the role of paracrine signaling by EGFR and Notch pathways in the activation of ER-negative breast cancer stem cells by estrogen
Fri Mar 08 00:00:00 EST 2013
Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer.
Gynecologic oncology
Argenta PA,Um I,Kay C,Harrison D,Faratian D,Sueblinvong T,Geller MA,Langdon SP
MA1-39540 was used in immunohistochemistry to study biomarkers capable of predicting the response of recurrent ovarian cancer to the estrogen receptor antagonist fulvestrant
Fri Nov 01 00:00:00 EDT 2013
Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?
Breast cancer research and treatment
Koo JS,Han K,Kim MJ,Moon HJ,Kim EK,Park BW
MA1-39540 was used in immunohistochemistry to study whether immunohistochemical analysis can replace surgery for diagnosing papillary breast cancer classified benign on needle biopsy
Fri Feb 01 00:00:00 EST 2013
Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling.
Breast cancer research and treatment
Thrane S,Lykkesfeldt AE,Larsen MS,Sorensen BS,Yde CW
MA1-39540 was used in western blot to study the key role of ER-alpha and the supporting roles of HER and ERK in the growth of breast cancer cells resistant to tamoxifen
Wed May 01 00:00:00 EDT 2013
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma.
Journal of cancer research and clinical oncology
Brunello E,Bogina G,Bria E,Vergine M,Zamboni G,Pedron S,Daniele I,Furlanetto J,Carbognin L,Marconi M,Manfrin E,Ibrahim M,Miller K,Tortora G,Molino A,Jasani B,Beccari S,Bonetti F,Chilosi M,Martignoni G,Brunelli M
MA1-39540 was used in immunohistochemistry to identify a subset of triple-negative breast cancer patients that will potentially benefit from anti-HER2 therapy
Sun Sep 01 00:00:00 EDT 2013
The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?
Acta oncologica (Stockholm, Sweden)
Grabau DA,Bendahl PO,Rydén L,Stål O,Fernö M
MA1-39540 was used in immunohistochemistry to examine the effects of antibody choice and the method used for heat-induced epitope retrieveal on the immunohistochemical measurement of ER in primary breast cancer patients
Fri Nov 01 00:00:00 EDT 2013
Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysis.
Breast (Edinburgh, Scotland)
Ingoldsby H,Webber M,Wall D,Scarrott C,Newell J,Callagy G
MA1-39540 was used in immunohistochemistry to study whether CART analysis of histopatholological and immunohistochemical markers can predict Oncotype DX and TAILORx risk categories
Tue Oct 01 00:00:00 EDT 2013
The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Breast (Edinburgh, Scotland)
Lai HW,Tseng LM,Chang TW,Kuo YL,Hsieh CM,Chen ST,Kuo SJ,Su CC,Chen DR
MA1-39540 was used in immunohistochemistry to study the prognostic implications of metaplastic carcinoma of the breast
Tue Oct 01 00:00:00 EDT 2013
The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers.
Breast (Edinburgh, Scotland)
Brouckaert O,Laenen A,Wildiers H,Floris G,Moerman P,Van Limbergen E,Vergote I,Billen J,Christiaens MR,Neven P
MA1-39540 was used in immunohistochemistry to study pre-operative and early post-operative levels of CA15.3 and their prognostic value in various types of primary operable breast cancers
Sat Jun 01 00:00:00 EDT 2013
Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors.
Oncology reports
Corrêa NC,Kuasne H,Faria JA,Seixas CC,Santos IG,Abreu FB,Nonogaki S,Rocha RM,Aparecida Borges Silva G,Gobbi H,Rogatto SR,Goes AM,Gomes DA
MA1-39540 was used in immunohistochemistry - paraffin section to characterize Brazilian breast cancer cell lines
Mon Apr 01 00:00:00 EDT 2013
Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study.
Gene
Fawzy MS,Aly NM,Shalaby SM,El-Sawy WH,Abdul-Maksoud RS
MA1-39540 was used in immunohistochemistry to study the relationship between COX-2 polymorphisms, PGE2 levels and breast cancer
Wed Sep 25 00:00:00 EDT 2013
Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ.
Human pathology
Shin SJ,Lal A,De Vries S,Suzuki J,Roy R,Hwang ES,Schnitt SJ,Waldman FM,Chen YY
MA1-39540 was used in immunohistochemistry to study the genomic and biomarker profiles of 20 cases of florid lobular carcinomas in situ
Tue Oct 01 00:00:00 EDT 2013
Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node.
Human pathology
Fitzpatrick-Swallow VL,Helin H,Cane P,Pinder SE
MA1-39540 was used in immunohistochemistry to report on a case of synchronous ductal carcinoma in situ of the breast within epithelial inclusions in an ipsilateral sentinel lymph node
Tue Jan 01 00:00:00 EST 2013
AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients.
Disease markers
Hrstka R,Brychtova V,Fabian P,Vojtesek B,Svoboda M
MA1-39540 was used in immunohistochemistry to study the value of ARG2 expression in predicting the response of post-menopausal breast cancer patients to tamoxifen therapy
Fri Jun 20 00:00:00 EDT 2014
Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas.
Journal of breast cancer
Do SI,Kim K,Kim DH,Chae SW,Park YL,Park CH,Sohn JH
MA1-39540 was used in immunohistochemistry to study the clinical and prognostic significance of the expression of MUC1, MUC2, MUC5AC and MUC6 in human breast ductal carcinomas
Sat Jun 01 00:00:00 EDT 2013
Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ.
Clinics (Sao Paulo, Brazil)
Aguiar FN,Mendes HN,Cirqueira CS,Bacchi CE,Carvalho FM
MA1-39540 was used in immunohistochemistry - paraffin section to learn about a new potential marker for low risk of invasion in ductal carcinoma in situ is called basal cytokeratin
Wed May 01 00:00:00 EDT 2013
Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Journal of surgical oncology
Park HS,Park S,Cho J,Park JM,Kim SI,Park BW
MA1-39540 was used in immunohistochemistry to study the issues associated with diagnosing ductal carcinoma in situ using core needle biopsy
Fri Mar 01 00:00:00 EST 2013
HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy.
Anticancer research
Brunelli M,Manfrin E,Bria E,Massari F,Tortora G,Brunello E,Carbognin L,Nottegar A,Furlanetto J,Molino A,Fiorio E,Chilosi M,Jasani B,Vergine M,Marcolini L,Filippini D,Scarpa A,Martignoni G,Bonetti F
MA1-39540 was used in immunohistochemistry to study the economic benefits of screening for HER2 gene amplification in breast carcinoma patients
Sun Sep 01 00:00:00 EDT 2013
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer.
Polish journal of pathology : official journal of the Polish Society of Pathologists
Gudlaugsson E,Klos J,Skaland I,Janssen EA,Smaaland R,Feng W,Shao Z,Malpica A,Baak JP
MA1-39540 was used in immunohistochemistry to study the prognostic value of a range of markers in T(1-2)N(0)M(0) breast cancer
Mon Apr 01 00:00:00 EDT 2013
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer.
BMC cancer
Madeira M,Mattar A,Logullo AF,Soares FA,Gebrim LH
MA1-39540 was used in immunohistochemistry to study the predictive value of estrogen receptor-beta in postmenopausal breast cancer patients undergoing endocrine therapy
Wed Sep 18 00:00:00 EDT 2013
A real-time spectral mapper as an emerging diagnostic technology in biomedical sciences.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Epitropou G,Kavvadias V,Iliou D,Stathopoulos E,Balas C
MA1-39540 was used in immunohistochemistry to describe a real-time spectral mapper suitable for dynamic bioimaging applications
Mon Aug 10 00:00:00 EDT 2015
Hormone receptors and age distribution in breast cancer patients at a university hospital in northern egypt.
Breast cancer : basic and clinical research
Hussein O,Mosbah M,Farouk O,Farag K,El-Saed A,Arafa M,Abdallah A
MA1-39540 was used in immunohistochemistry to study whether there is a relationship between hormone receptor status, age profile, and clinicopathology in northern Egyptian breast cancer patients
Fri Jul 05 00:00:00 EDT 2013
Prognostic significance of deregulated dicer expression in breast cancer.
PloS one
Caffrey E,Ingoldsby H,Wall D,Webber M,Dinneen K,Murillo LS,Inderhaug C,Newell J,Gupta S,Callagy G
MA1-39540 was used in immunohistochemistry to study the prognostic value of Dicer expression in patients with breast cancer
Tue Sep 16 00:00:00 EDT 2014
Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.
Applied immunohistochemistry & molecular morphology : AIMM
Gill MS,Paish EC,Ronan J,Green AR,Ellis IO,Lee AH
MA1-39540 was used in immunohistochemistry to study the PharmDx system for the immunohistochemical detection of ER and PR in breast cancer.
Tue Jan 01 00:00:00 EST 2013
An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.
International journal of clinical and experimental pathology
Zhang J,Wang Y,Yin Q,Zhang W,Zhang T,Niu Y
MA1-39540 was used in immunohistochemistry (paraffin) to study triple negative breast cancer in Chinese women.
Fri Feb 07 00:00:00 EST 2014
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Bjerre C,Vinther L,Belling KC,Würtz SØ,Yadav R,Lademann U,Rigina O,Do KN,Ditzel HJ,Lykkesfeldt AE,Wang J,Nielsen HB,Brünner N,Gupta R,Schrohl AS,Stenvang J
MA1-39540 was used in western blot to study the correlation between high TIMP1 levels, low PR expression and resistance to fulvestrant in human MCF-7 breast cancer cell lines
Sun Dec 01 00:00:00 EST 2013
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology
Brouckaert O,Laenen A,Vanderhaegen J,Wildiers H,Leunen K,Amant F,Berteloot P,Smeets A,Paridaens R,Christiaens MR,Floris G,Moerman P,Van Limbergen E,Peeters S,Weltens C,Vergote I,Neven P
MA1-39540 was used in immunohistochemistry to study the prognostic value of the 2011 St Gallen panel of markers in primary operable breast cancer
Mon Oct 01 00:00:00 EDT 2012
TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation.
Nature cell biology
Chio II,Sasaki M,Ghazarian D,Moreno J,Done S,Ueda T,Inoue S,Chang YL,Chen NJ,Mak TW
MA1-39540 was used in immunohistochemistry to study the mechanism by which TRADD contributes to tumor suppression
Sun May 06 00:00:00 EDT 2012
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
EMBO molecular medicine
Park YY,Kim K,Kim SB,Hennessy BT,Kim SM,Park ES,Lim JY,Li J,Lu Y,Gonzalez-Angulo AM,Jeong W,Mills GB,Safe S,Lee JS
MA1-39540 was used in western blot to study the modulation of the ESR1 transcription factor by NR2E3 in breast cancer cells
Sun Jan 01 00:00:00 EST 2012
Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Cancer research
Giulianelli S,Vaqué JP,Soldati R,Wargon V,Vanzulli SI,Martins R,Zeitlin E,Molinolo AA,Helguero LA,Lamb CA,Gutkind JS,Lanari C
MA1-39540 was used in western blot to study the molecular mechanism underlying the ER-alpha-mediated stimulation of mammary tumor growth by progestin
Tue May 01 00:00:00 EDT 2012
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.
Journal of the National Cancer Institute
Neumeister VM,Anagnostou V,Siddiqui S,England AM,Zarrella ER,Vassilakopoulou M,Parisi F,Kluger Y,Hicks DG,Rimm DL
MA1-39540 was used in immunohistochemistry and western blot to study the effect of the period of pre-analysis cold ischemia on the antigenicity of a number of breast cancer proteins
Wed Dec 05 00:00:00 EST 2012
Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens.
Fertility and sterility
Kasai M,Ichimura T,Kawamura N,Sumikura T,Matsuda M,Asano C,Sumi T,Ishiko O
MA1-39540 was used in immunohistochemistry to study the relationship between the shrinking of uterine leiomyoma nodules and the expression of ER, PR and VEGF following menopause or pharmacological treatment
Wed Aug 01 00:00:00 EDT 2012
The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years.
International journal of cancer
Zheng S,Bai JQ,Li J,Fan JH,Pang Y,Song QK,Huang R,Yang HJ,Xu F,Lu N,Qiao YL
MA1-39540 was used in immunohistochemistry to study the pathologic characteristics of breast cancer in China and its shift during 1999-2008
Sat Dec 01 00:00:00 EST 2012
Clinical significance of KISS1 protein expression for brain invasion and metastasis.
Cancer
Ulasov IV,Kaverina NV,Pytel P,Thaci B,Liu F,Hurst DR,Welch DR,Sattar HA,Olopade OI,Baryshnikov AY,Kadagidze ZG,Lesniak MS
MA1-39540 was used in immunohistochemistry to study the clinical value of KISS1 expression in predicting brain invasion and metastasis in breast cancer patients
Sun Apr 15 00:00:00 EDT 2012
Breast cancers presenting luminal B subtype features show higher discordant human epidermal growth factor receptor 2 results between immunohistochemistry and fluorescence in situ hybridization.
Cancer
Park S,Park HS,Koo JS,Yang WI,Kim SI,Park BW
MA1-39540 was used in immunohistochemistry to study the differences in HER2 as measured by immunohistochemistry and FISH in invasive breast cancers and the prognostic and clinical significance
Wed Feb 15 00:00:00 EST 2012
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
The American journal of surgical pathology
Lee CH,Mariño-Enriquez A,Ou W,Zhu M,Ali RH,Chiang S,Amant F,Gilks CB,van de Rijn M,Oliva E,Debiec-Rychter M,Dal Cin P,Fletcher JA,Nucci MR
MA1-39540 was used in immunohistochemistry to report on the clinical and pathological features of 13 cases of YWHAE-FAM22 endometrial stromal sarcoma
Tue May 01 00:00:00 EDT 2012
Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
International journal of oncology
Grell P,Fabian P,Khoylou M,Radova L,Slaby O,Hrstka R,Vyzula R,Hajduch M,Svoboda M
MA1-39540 was used in immunohistochemistry to study the predictive value of Akt expression and compartmentalization in trastuzumab-treated HER2-positive metastatic breast cancer
Mon Oct 01 00:00:00 EDT 2012
Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor.
The oncologist
Macfarlane R,Seal M,Speers C,Woods R,Masoudi H,Aparicio S,Chia SK
MA1-39540 was used in immunohistochemistry to study changes in biomarker expression between primary breast cancer and relapsed metastatic tumors using paired tissue microarray analysis
Mon Jun 25 00:00:00 EDT 2012
Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review.
Cancer biology & medicine
Hao JY,Yang CC,Liu FF,Yang YL,Li S,Li WD,Li YQ,Lang RG,Fan Y,Paulos E,Zhang XM,Fu L
MA1-39540 was used in immunohistochemistry to report and characterize two cases of accessory breast cancer occurring concurrently with primary invasive breast cancer.
Sat Sep 01 00:00:00 EDT 2012
Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.
Translational oncology
Bock C,Rack B,Kuhn C,Hofmann S,Finkenzeller C,Jäger B,Jeschke U,Doisneau-Sixou SF
MA1-39540 was used in immunocytochemistry and western blot to study differences in the ER-alpha and ErbB2 staus of circulating tumor cells as compared to cell lines in patients with metastatic breast cancer
Sat Dec 01 00:00:00 EST 2012
Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Roelofsen T,van Kempen LC,van der Laak JA,van Ham MA,Bulten J,Massuger LF
MA1-39540 was used in immunohistochemistry to investigate the relation between endometrial intraepithelial carcinoma and serous ovarian carcinoma
Thu Mar 01 00:00:00 EST 2012
Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing?
Breast cancer research and treatment
Allison KH,Kandalaft PL,Sitlani CM,Dintzis SM,Gown AM
MA1-39540 was used in immunohistochemistry to study whether standard pathological parameters are predictive of Oncotype DX scores in a subset of estrogen receptor-positive breast cancer patients
Sun Jan 01 00:00:00 EST 2012
The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer.
Breast cancer research and treatment
Jonsdottir K,Zhang H,Jhagroe D,Skaland I,Slewa A,Björkblom B,Coffey ET,Gudlaugsson E,Smaaland R,Janssen EA,Baak JP
MA1-39540 was used in immunohistochemistry to study the prognostic value of MARCKS-like1 expression in patients with lymph node-negative breast cancer
Sat Sep 01 00:00:00 EDT 2012
Cytologic features of triple-negative breast carcinoma.
Cancer cytopathology
Bonzanini M,Morelli L,Bonandini EM,Leonardi E,Pertile R,Dalla Palma P
MA1-39540 was used in immunohistochemistry to study the cytologic features of triple-negative breast carcinoma
Tue Dec 25 00:00:00 EST 2012
mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors.
Breast (Edinburgh, Scotland)
Walsh S,Flanagan L,Quinn C,Evoy D,McDermott EW,Pierce A,Duffy MJ
MA1-39540 was used in immunohistochemistry to investigate the mTOR expression in triple-negative and non-triple-negative tumors
Sun Apr 01 00:00:00 EDT 2012
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
Breast (Edinburgh, Scotland)
Park S,Koo JS,Kim MS,Park HS,Lee JS,Lee JS,Kim SI,Park BW
MA1-39540 was used in immunohistochemistry to perform immunohistochemical molecular subtyping of breast cancer
Wed Feb 01 00:00:00 EST 2012
The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast.
Human pathology
Choi Y,Kim EJ,Seol H,Lee HE,Jang MJ,Kim SM,Kim JH,Kim SW,Choe G,Park SY
MA1-39540 was used in immunohistochemistry to characterize ER, PR, HER-2 subtypes in multifocal/multicentric breast cancers
Sun Jan 01 00:00:00 EST 2012
Implementation of TMA and digitalization in routine diagnostics of breast pathology.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Rossing HH,Talman ML,Laenkholm AV,Wielenga VT
MA1-39540 was used in immunohistochemistry to study the implementation of tissue microarrays and digitalization in routine diagnosis of breast pathology
Sun Apr 01 00:00:00 EDT 2012
Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Bartel F,Balschun K,Gradhand E,Strauss HG,Dittmer J,Hauptmann S
MA1-39540 was used in immunohistochemistry to study the diagnostic and prognostic value of cystein-rich 61 and connective tissue growth factor expression in borderline ovarian tumors and carcinomas
Sat Sep 01 00:00:00 EDT 2012
Clinicopathologic features of the mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation in a subset of six cases.
Pathology, research and practice
Yigit S,Pehlivan FS,Evcim G,Etit D
MA1-39540 was used in immunohistochemistry to study six cases of mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation
Thu Mar 15 00:00:00 EDT 2012
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers.
Cancer chemotherapy and pharmacology
Lin C,Chen DR,Chang KJ,Chang TW,Wang HC
MA1-39540 was used in immunohistochemistry to perform a T2 breast cancer phase II clincal trial to study the response to combined treatment with docataxel, cisplatin and trastuzumab
Tue May 01 00:00:00 EDT 2012
Histological analysis of benign breast imaging reporting and data system categories 4c and 5 breast lesions in imaging study.
Yonsei medical journal
Kim MJ,Kim D,Jung W,Koo JS
MA1-39540 was used in immunohistochemistry to study the histology of breast lesions categorized as BI-RADS 4c or 5 breast lesions during image analysis but subsequently diagnosed benign
Thu Nov 01 00:00:00 EDT 2012
Homeodomain-interacting protein kinase 1 (HIPK1) expression in breast cancer tissues.
Japanese journal of clinical oncology
Park BW,Park S,Koo JS,Kim SI,Park JM,Cho JH,Park HS
MA1-39540 was used in immunohistochemistry to study the expression of HIPK1 in breast cancer tissue
Sat Dec 01 00:00:00 EST 2012
A 10-year follow-up of triple-negative breast cancer patients in Taiwan.
Japanese journal of clinical oncology
Lin C,Chien SY,Kuo SJ,Chen LS,Chen ST,Lai HW,Chang TW,Chen DR
MA1-39540 was used in immunohistochemistry to report on a 10-year follow-up of Taiwanese triple-negative breast cancer patients
Thu Mar 01 00:00:00 EST 2012
Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
Pathology oncology research : POR
El-Gendi SM,Mostafa MF,El-Gendi AM
MA1-39540 was used in immunohistochemistry to study the prognostic value of stromal caveolin-1 in breast cancer
Sun Apr 01 00:00:00 EDT 2012
Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers.
Experimental and therapeutic medicine
Rau KM,Huang CC,Chiu TJ,Chen YY,Lu CC,Liu CT,Pei SN,Wei YC
MA1-39540 was used in immunohistochemistry to study the prognostic value of CD105 expression in breast cancers
Wed Aug 01 00:00:00 EDT 2012
Increased FDG uptake in breast cancer is associated with prognostic factors.
Annals of nuclear medicine
Sanli Y,Kuyumcu S,Ozkan ZG,Işik G,Karanlik H,Guzelbey B,Turkmen C,Ozel S,Yavuz E,Mudun A
MA1-39540 was used in immunohistochemistry to study the relationship between FDG uptake and prognostic factors in breast cancer
Tue May 01 00:00:00 EDT 2012
Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients.
Indian journal of pathology & microbiology
Makroo RN,Chowdhry M,Kumar M,Srivastava P,Tyagi R,Bhadauria P,Kaul S,Sarin R,Das PK,Dua H
MA1-39540 was used in immunohistochemistry to compare the use of FISH and immunohistochemistry for measuring changes in HER2 in breast cancer patients
Mon Nov 18 00:00:00 EST 2013
A new case of primary signet-ring cell carcinoma of the cervix with prominent endometrial and myometrial involvement: Immunohistochemical and molecular studies and review of the literature.
World journal of surgical oncology
Giordano G,Pizzi S,Berretta R,D'Adda T
MA1-39540 was used in immunohistochemistry to report on a case of primary signet-ring cell carcinoma of the cervix with endometrial and myometrial involvement
Wed Jan 11 00:00:00 EST 2012
Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ.
PloS one
Powell E,Shanle E,Brinkman A,Li J,Keles S,Wisinski KB,Huang W,Xu W
MA1-39540 was used in immunocytochemistry to study the function of estrogen receptor heterodimers in cells co-expressing ERalpha and ERbeta
Tue Jul 31 00:00:00 EDT 2012
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.
Journal of experimental & clinical cancer research : CR
Brunello E,Brunelli M,Bogina G,Caliò A,Manfrin E,Nottegar A,Vergine M,Molino A,Bria E,Massari F,Tortora G,Cingarlini S,Pedron S,Chilosi M,Zamboni G,Miller K,Martignoni G,Bonetti F
MA1-39540 was used in immunohistochemistry to study FGFR-1 gene amplification in primary lobular breast cancer and its metastases
Thu Dec 27 00:00:00 EST 2012
Vaginal superficial myofibroblastoma: a rare mesenchymal tumor of the lower female genital tract and a study of its association with viral infection.
Medical molecular morphology
Liu JL,Su TC,Shen KH,Lin SH,Wang HK,Hsu JC,Chen CJ
MA1-39540 was used in immunohistochemistry to report on a case of vaginal superficial myofibroblastoma
Fri Jun 01 00:00:00 EDT 2012
Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival.
PloS one
Cawthorn TR,Moreno JC,Dharsee M,Tran-Thanh D,Ackloo S,Zhu PH,Sardana G,Chen J,Kupchak P,Jacks LM,Miller NA,Youngson BJ,Iakovlev V,Guidos CJ,Vallis KA,Evans KR,McCready D,Leong WL,Done SJ
MA1-39540 was used in immunohistochemistry to identify prognostic biomarkers in breast cancer patients using proteomoc analysis
Fri Jun 29 00:00:00 EDT 2012
Invasive lobular carcinoma with extracellular mucin as a distinct variant of lobular carcinoma: a case report.
Diagnostic pathology
Haltas H,Bayrak R,Yenidunya S,Kosehan D,Sen M,Akin K
MA1-39540 was used in immunohistochemistry to report on a case of invasive lobular carcinoma with extracellular mucin
Mon Aug 06 00:00:00 EDT 2012
Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases.
Clinical medicine insights. Case reports
Carvalho FM,Carvalho JP,Pereira RM,Ceccato BP,Lacordia R,Baracat EC
MA1-39540 was used in immunohistochemistry to present two cases of leiomyomatosis peritonealis
Thu Aug 30 00:00:00 EDT 2012
MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
Diagnostic pathology
Svoboda M,Sana J,Redova M,Navratil J,Palacova M,Fabian P,Slaby O,Vyzula R
MA1-39540 was used in immunohistochemistry to study the prognostic value of microRNA-34b expression in triple-negative breast cancer patients
Thu Mar 22 00:00:00 EDT 2012
Arginase activity in patients with breast cancer: an analysis of plasma, tumors, and its relationship with the presence of the estrogen receptor.
Onkologie
Perez G,Olivares IM,Rodriguez MG,Ceballos GM,Garcia Sanchez JR
MA1-39540 was used in immunohistochemistry to study plasma and tumor levels of arginase activity in breast cancer patients and whether there is any relationship with estrogen receptor presence
Fri Mar 22 00:00:00 EDT 2013
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology
Park S,Koo JS,Kim MS,Park HS,Lee JS,Lee JS,Kim SI,Park BW,Lee KS
MA1-39540 was used in immunohistochemistry to study the association of androgen receptor expression with better outcomes in estrogen receptor-positive breast cancers
Mon Aug 01 00:00:00 EDT 2011
Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology
Chuah BY,Putti T,Salto-Tellez M,Charlton A,Iau P,Buhari SA,Wong CI,Tan SH,Wong AL,Chan CW,Goh BC,Lee SC
MA1-39540 was used in immunohistochemistry to detect protein expression responses to neoadjuvant chemotherapy
Mon Aug 01 00:00:00 EDT 2011
Dietary patterns and risk of breast cancer.
British journal of cancer
Baglietto L,Krishnan K,Severi G,Hodge A,Brinkman M,English DR,McLean C,Hopper JL,Giles GG
MA1-39540 was used in immunohistochemistry to study the significance of diet in breast cancer risk
Tue Feb 01 00:00:00 EST 2011
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.
Breast cancer research : BCR
Teng YH,Tan WJ,Thike AA,Cheok PY,Tse GM,Wong NS,Yip GW,Bay BH,Tan PH
MA1-39540 was used in immunohistochemistry - paraffin section to study EGFR gene in triple negative breast cancer and its therapeutic application
Fri Apr 01 00:00:00 EDT 2011
D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Gudlaugsson E,Skaland I,Undersrud E,Janssen EA,Søiland H,Baak JP
MA1-39540 was used in immunohistochemistry to investigate the prognostic value of lymph vessel invasion identified by D2-40/p63 in lymph-node negative invasive breast cancer patients
Fri Apr 01 00:00:00 EDT 2011
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
Breast cancer research and treatment
Loibl S,Müller BM,von Minckwitz G,Schwabe M,Roller M,Darb-Esfahani S,Ataseven B,du Bois A,Fissler-Eckhoff A,Gerber B,Kulmer U,Alles JU,Mehta K,Denkert C
MA1-39540 was used in immunohistochemistry to study the predictive and prognostic value of androgen receptor expression in primary breast cancer treated with neoadjuvant chemotherapy
Tue Nov 01 00:00:00 EDT 2011
Amplification of the prolactin receptor gene in mammary lobular neoplasia.
Breast cancer research and treatment
Tran-Thanh D,Arneson NC,Pintilie M,Deliallisi A,Warren KS,Bane A,Done SJ
MA1-39540 was used in immunohistochemistry to study amplification of the prolactin receptor gene in mammary neoplasia.
Fri Jul 01 00:00:00 EDT 2011
Promoter CpG island hypermethylation during breast cancer progression.
Virchows Archiv : an international journal of pathology
Park SY,Kwon HJ,Lee HE,Ryu HS,Kim SW,Kim JH,Kim IA,Jung N,Cho NY,Kang GH
MA1-39540 was used in immunohistochemistry to study changes in promoter CpG island hypermethylation during breast cancer progression
Sat Jan 01 00:00:00 EST 2011
Estrogen-independent actions of environmentally relevant AhR-agonists in human endometrial epithelial cells.
Molecular human reproduction
Willing C,Peich M,Danescu A,Kehlen A,Fowler PA,Hombach-Klonisch S
MA1-39540 was used in western blot to study the effect of environmental arylhydrocarbon receptor agonists on human endometrial epithelial cells
Tue Feb 01 00:00:00 EST 2011
Dendritic cells treated with HPV16mE7 in a three-dimensional model promote the secretion of IL-12p70 and IFN-γ.
Experimental and molecular pathology
Wang YT,Li W,Liu Q,Guan X,Hu J
MA1-39540 was used in immunocytochemistry to investigate the immune response of dendritic cells after treatment with the HPV16E7 DNA vaccine
Mon Aug 01 00:00:00 EDT 2011
Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 cases.
Breast (Edinburgh, Scotland)
Yip CH,Pathy NB,Uiterwaal CS,Taib NA,Tan GH,Mun KS,Choo WY,Rhodes A
MA1-39540 was used in immunohistochemistry to investigate the change of ER positive rates in breast cancers over a 15-year period in a tertiary hospital in Malaysia
Fri Apr 01 00:00:00 EDT 2011
Effects of long-term storage on the detection of proteins, DNA, and mRNA in tissue microarray slides.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Karlsson C,Karlsson MG
MA1-39540 was used in immunohistochemistry to study the ability to detect proteins, DNA and mRNA on tissue microarray slides following long term storage
Thu Dec 01 00:00:00 EST 2011
Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Lai HW,Kuo SJ,Chen LS,Chi CW,Chen ST,Chang TW,Chen DR
MA1-39540 was used in immunohistochemistry to study the prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller
Sat Jan 01 00:00:00 EST 2011
May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis.
Medical oncology (Northwood, London, England)
Wang H,Guan B,Shi Q,Ma H,Zhou H,Wang X,Zhou X
MA1-39540 was used in immunohistochemistry to study the basal-like carcinoma characteristics of metaplastic breast carcinomas
Tue Mar 01 00:00:00 EST 2011
Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy.
Oncology
Keskin S,Muslumanoglu M,Saip P,Karanlık H,Guveli M,Pehlivan E,Aydoğan F,Eralp Y,Aydıner A,Yavuz E,Ozmen V,Igci A,Topuz E
MA1-39540 was used in immunohistochemistry to identify factors predictive of pathological complete response to anthracycline-based neoadjuvant chemotherapy
Wed Dec 07 00:00:00 EST 2011
Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Oncology
Nikolényi A,Sükösd F,Kaizer L,Csörgo E,Vörös A,Uhercsák G,Ormándi K,Lázár G,Thurzó L,Brodowicz T,Kahán Z
MA1-39540 was used in immunohistochemistry to study tumor topoisomerase II alpha status as a marker of sensitivity to anthracycline-based neoadjuvant chemotherapy in breast cancer
Wed Sep 28 00:00:00 EDT 2011
Molecular phenotypes of matched in situ and invasive components of breast carcinomas.
Human pathology
Martins D,Sousa B,Lopes N,Gomes M,Veronese L,Albergaria A,Paredes J,Schmitt F
MA1-39540 was used in immunohistochemistry to compare the tissue microarray immunoprofiles of in situ and invasive breast carcinoma components within the same sample
Sat Oct 01 00:00:00 EDT 2011
Correlation of histologic grade with other clinicopathological parameters, intrinsic subtype, and patients' clinical outcome in Taiwanese women.
Japanese journal of clinical oncology
Chen ST,Lai HW,Tseng HS,Chen LS,Kuo SJ,Chen DR
MA1-39540 was used in immunohistochemistry to study the relationship between histologic grade and clinicopathological parameters in Taiwanese breast cancer patients
Thu Dec 01 00:00:00 EST 2011
The feasibility of endoscopy-assisted breast conservation surgery for patients with early breast cancer.
Journal of breast cancer
Park HS,Lee JS,Lee JS,Park S,Kim SI,Park BW
MA1-39540 was used in immunohistochemistry to evaluate the effectiveness of endoscopy-assisted breast conservation surgery for breast cancer patients
Tue Mar 01 00:00:00 EST 2011
Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.
Clinics (Sao Paulo, Brazil)
Carvalho ST,Stiepcich MM,Fregnani JH,Nonogaki S,Rocha R,Soares FA
MA1-39540 was used in immunohistochemistry to study prognostic and mortality risk factors in stage IIA breast tumors
Wed Dec 28 00:00:00 EST 2011
Estrogen receptor expression in sporadic vestibular schwannomas.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Brown CM,Ahmad ZK,Ryan AF,Doherty JK
MA1-39540 was used in western blot to study whether expression of the estrogen receptor is upregulated in sporadic vestibular schwannomas
Sat Jan 01 00:00:00 EST 2011
Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival.
Archives of gynecology and obstetrics
Ege CB,Akbulut M,Zekioğlu O,Ozdemir N
MA1-39540 was used in immunohistochemistry to investigate the effect of galectin-3 and heparanase on the pathogenesis of endometrial carcinomas
Tue Nov 01 00:00:00 EDT 2011
Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters.
Scandinavian journal of clinical and laboratory investigation
Naidu R,Har YC,Taib NA
MA1-39540 was used in immunohistochemistry to analyze the polymorphism of peptidyl-propyl-cis/trans isomerase 1 in breast cancer
Sat Oct 01 00:00:00 EDT 2011
A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.
International journal of surgical pathology
Baydar DE,Kulac I,Gurel B,De Marzo A
MA1-39540 was used in immunohistochemistry to report a new clinical case of prostatic adenomas with abnormal p63 expression
Tue Feb 01 00:00:00 EST 2011
Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
British journal of neurosurgery
Abdelzaher E,El-Gendi SM,Yehya A,Gowil AG
MA1-39540 was used in immunohistochemistry to identify biomarkers that predict the recurrence of benign meningiomas
Thu Dec 01 00:00:00 EST 2011
Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.
Diagnostic molecular pathology : the American journal of surgical pathology, part B
Müller BM,Kronenwett R,Hennig G,Euting H,Weber K,Bohmann K,Weichert W,Altmann G,Roth C,Winzer KJ,Kristiansen G,Petry C,Dietel M,Denkert C
MA1-39540 was used in immunohistochemistry to study the expression levels of estrogen receptor, progesterone receptor and HER2 in formalin-fixed paraffin-embedded human breast cancer tissues
Tue Mar 01 00:00:00 EST 2011
Sclerosing polycystic adenosis of the parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking invasive carcinoma.
Head and neck pathology
Petersson F,Tan PH,Hwang JS
MA1-39540 was used in immunohistochemistry to report a rare clinical case of sclerosing polycystic adenosis of the parotid gland
Wed Jun 01 00:00:00 EDT 2011
Unusual finding of endocervical-like mucinous epithelium in continuity with urothelium in endocervicosis of the urinary bladder.
Diagnostic pathology
Cheah PL,Looi LM,Lee GE,Teoh KH,Mun KS,Nazarina AR
MA1-39540 was used in immunohistochemistry - paraffin section to describe a case of endocervicosis in a 37-year-old woman
Thu Jun 23 00:00:00 EDT 2011
Expression of androgen receptors in primary breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology
Park S,Koo J,Park HS,Kim JH,Choi SY,Lee JH,Park BW,Lee KS
MA1-39540 was used in immunohistochemistry to investigate the androgen receptor expression level in breast cancer
Mon Mar 01 00:00:00 EST 2010
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Baehner FL,Achacoso N,Maddala T,Shak S,Quesenberry CP,Goldstein LC,Gown AM,Habel LA
MA1-39540 was used in immunohistochemistry to study the best method for assessing HER2 status in cancer patients
Fri Oct 01 00:00:00 EDT 2010
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.
The Journal of clinical investigation
Miller TW,Hennessy BT,González-Angulo AM,Fox EM,Mills GB,Chen H,Higham C,García-Echeverría C,Shyr Y,Arteaga CL
MA1-39540 was used in immunocytochemistry to study the role of PI3 kinase hyperactivation in the escape from hormone dependence in estrogen receptor-positive breast cancer
Thu Jul 01 00:00:00 EDT 2010
The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis.
Biomaterials
Chen C,Xia HS,Gong YP,Peng J,Peng CW,Hu MB,Zhu XB,Pang DW,Sun SR,Li Y
MA1-39540 was used in immunohistochemistry to evaluate a quantum dot-based nanotechnology for breast cancer prognosis
Mon Nov 01 00:00:00 EDT 2010
An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
Cancer research
Wynendaele J,Böhnke A,Leucci E,Nielsen SJ,Lambertz I,Hammer S,Sbrzesny N,Kubitza D,Wolf A,Gradhand E,Balschun K,Braicu I,Sehouli J,Darb-Esfahani S,Denkert C,Thomssen C,Hauptmann S,Lund A,Marine JC,Bartel F
MA1-39540 was used in immunohistochemistry to study the role of an illegitimate miR-191 target site within the 3' UTR of MDM4 in ovarian cancer
Wed Dec 01 00:00:00 EST 2010
Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.
Cancer research
Spillman MA,Manning NG,Dye WW,Sartorius CA,Post MD,Harrell JC,Jacobsen BM,Horwitz KB
MA1-39540 was used in immunohistochemistry to investigate the association of menopausal estrogen replacement therapy with ovarian cancer growth and metastasis
Mon Nov 01 00:00:00 EDT 2010
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
The Journal of pathology
Faggad A,Budczies J,Tchernitsa O,Darb-Esfahani S,Sehouli J,Müller BM,Wirtz R,Chekerov R,Weichert W,Sinn B,Mucha C,Elwali NE,Schäfer R,Dietel M,Denkert C
MA1-39540 was used in immunohistochemistry to study the prognostic value of Dicer expression in ovarian cancer
Mon Feb 01 00:00:00 EST 2010
The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.
Oncogene
Hrstka R,Nenutil R,Fourtouna A,Maslon MM,Naughton C,Langdon S,Murray E,Larionov A,Petrakova K,Muller P,Dixon MJ,Hupp TR,Vojtesek B
MA1-39540 was used in western blot to evaluate pro-metastatic protein anterior gradient-2 as the prognostic marker for tamoxifen-treatment of breast cancers
Thu Aug 26 00:00:00 EDT 2010
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Thike AA,Cheok PY,Jara-Lazaro AR,Tan B,Tan P,Tan PH
MA1-39540 was used in immunohistochemistry to investigate the clinicopathological characteristics of triple-negative breast cancer and its relationship with basal-like breast cancer
Fri Jan 01 00:00:00 EST 2010
Biologic profiling of lymph node negative breast cancers by means of microRNA expression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Janssen EA,Slewa A,Gudlaugsson E,Jonsdottir K,Skaland I,Søiland H,Baak JP
MA1-39540 was used in western blot to categorize lymph node negative breast cancers through microRNA expression
Wed Dec 01 00:00:00 EST 2010
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Lwin ZM,Guo C,Salim A,Yip GW,Chew FT,Nan J,Thike AA,Tan PH,Bay BH
MA1-39540 was used in immunohistochemistry to investigate the prognostic significance of calreticulin in advanced tumors
Wed Dec 01 00:00:00 EST 2010
Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
Endocrine-related cancer
Rasmussen LM,Frederiksen KS,Din N,Galsgaard E,Christensen L,Berchtold MW,Panina S
MA1-39540 was used in western blot to study the interaction between prolactin and oestrogen in breast cancer cells
Wed Sep 01 00:00:00 EDT 2010
The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas.
American journal of clinical pathology
Rhodes A,Sarson J,Assam EE,Dean SJ,Cribb EC,Parker A
MA1-39540 was used in immunohistochemistry to investigate the reliability of rabbit monoclonal antibody immunohistochemical testing
Fri Oct 01 00:00:00 EDT 2010
Citraconic anhydride: a new antigen retrieval solution.
Pathology
Leong AS,Haffajee Z
MA1-39540 was used in immunohistochemistry - paraffin section to discuss factors that influence heat-induced antigen retrieval
Fri Jan 01 00:00:00 EST 2010
A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast.
Pathology
Pathmanathan N,Salisbury EL,Provan PJ,Bilous AM,Byth K,Milliken JS,Clarke CL,Balleine RL
MA1-39540 was used in immunohistochemistry to evaluate a novel method for the classification of breast columnar cell lesions
Fri Jan 01 00:00:00 EST 2010
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.
Clinical proteomics
Hennessy BT,Lu Y,Gonzalez-Angulo AM,Carey MS,Myhre S,Ju Z,Davies MA,Liu W,Coombes K,Meric-Bernstam F,Bedrosian I,McGahren M,Agarwal R,Zhang F,Overgaard J,Alsner J,Neve RM,Kuo WL,Gray JW,Borresen-Dale AL,Mills GB
MA1-39540 was used in western blot to study the use of reverse phase protein arrays for analysing the functional proteome in non-microdissected human breast cancers
Wed Dec 01 00:00:00 EST 2010
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Breast cancer research and treatment
Liu S,Chia SK,Mehl E,Leung S,Rajput A,Cheang MC,Nielsen TO
MA1-39540 was used in immunohistochemistry to study the prognostic value of the progesterone receptor in adjuvant tamoxifen therapy of breast cancer
Fri Jan 01 00:00:00 EST 2010
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.
Breast cancer research and treatment
Huober J,von Minckwitz G,Denkert C,Tesch H,Weiss E,Zahm DM,Belau A,Khandan F,Hauschild M,Thomssen C,Högel B,Darb-Esfahani S,Mehta K,Loibl S
MA1-39540 was used in immunohistochemistry to study the effect of neoadjuvant anthracycline-taxane-based chemotherapy in different breast cancer phenotypes
Mon Nov 01 00:00:00 EDT 2010
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.
Breast cancer research and treatment
Gudlaugsson E,Skaland I,Janssen EA,van Diest PJ,Voorhorst FJ,Kjellevold K,zur Hausen A,Baak JP
MA1-39540 was used in immunohistochemistry to evaluate the prognostic factors for lymph node negative lobular invasive breast cancer
Sat May 01 00:00:00 EDT 2010
Protein and gene expression of estrogen receptor alpha and nuclear morphology of two breast cancer cell lines after different fixation methods.
Experimental and molecular pathology
Nykänen M,Kuopio T
MA1-39540 was used in immunohistochemistry to evaluate different tissue fixation methods for the measurement of estrogen receptor alpha an in breast cancer cell lines
Thu Apr 01 00:00:00 EDT 2010
Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Oncology
Kim SI,Sohn J,Koo JS,Park SH,Park HS,Park BW
MA1-39540 was used in immunohistochemistry to evaluate the neoadjuvant chemotherapy in breast cancer patients
Thu Jun 30 00:00:00 EDT 2011
Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification.
Human pathology
Vranic S,Frkovic-Grazio S,Lamovec J,Serdarevic F,Gurjeva O,Palazzo J,Bilalovic N,Lee LM,Gatalica Z
MA1-39540 was used in immunohistochemistry to profile the expression of selected proteins in adenoid cystic carcinoma.
Mon Nov 01 00:00:00 EDT 2010
Clinicopathologic features of 2 new cases of uterine tumors resembling ovarian sex cord tumors.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Giordano G,Lombardi M,Brigati F,Mancini C,Silini EM
MA1-39540 was used in immunohistochemistry to report on two cases of uterine tumors resembling ovarian sex cord tumors
Wed Sep 01 00:00:00 EDT 2010
High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Alkushi A,Köbel M,Kalloger SE,Gilks CB
MA1-39540 was used in immunohistochemistry to investigate the differences between grade 3 and serous endometrial carcinoma
Thu Jul 01 00:00:00 EDT 2010
Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
Research in veterinary science
Chang CY,Chiou PP,Chen WJ,Li YH,Yiu JC,Cheng YH,Chen SD,Lin CT,Lai YS
MA1-39540 was used in western blot to study the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines
Thu Apr 01 00:00:00 EDT 2010
Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary.
Archives of gynecology and obstetrics
Zekioglu O,Ozdemir N,Terek C,Ozsaran A,Dikmen Y
MA1-39540 was used in immunohistochemistry to characterize ovarian sclerosing stromal tumours
Wed Dec 01 00:00:00 EST 2010
Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters.
Archives of gynecology and obstetrics
Gul A,Ugur M,Iskender C,Zulfikaroglu E,Ozaksit G
MA1-39540 was used in immunohistochemistry to investigate the expression levels of steroid hormone receptors in endometrial polyps
Mon Mar 01 00:00:00 EST 2010
Papillary apocrine metaplasia and columnar cell lesion with atypia: is there a shared common pathway?
Annals of diagnostic pathology
Kosemehmetoglu K,Guler G
MA1-39540 was used in immunohistochemistry to study the possibility of a common pathogenic pathway in papillary apocrine metaplasia and columnar cell lesion with atypia
Wed Dec 01 00:00:00 EST 2010
Primary adenocarcinoma of the rectovaginal septum arising in pregnancy in the absence of endometriosis.
European journal of gynaecological oncology
Giordano G,Bersiga A,Marchetti G,Melpignano M
MA1-39540 was used in immunohistochemistry to report on a case of primary adenocarcinoma of the rectovaginal septum arising in pregnancy in the absence of endometriosis
Mon Jun 28 00:00:00 EDT 2010
Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
Applied immunohistochemistry & molecular morphology : AIMM
Gomez-Fernandez C,Mejias A,Walker G,Nadji M
MA1-39540 was used in immunohistochemistry to investigate the expression of estrogen receptor alpha in proven primary lung adenocarcinomas cases
Mon Mar 01 00:00:00 EST 2010
The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin.
Molecular cancer
Kvardova V,Hrstka R,Walerych D,Muller P,Matoulkova E,Hruskova V,Stelclova D,Sova P,Vojtesek B
MA1-39540 was used in western blot to study a novel platinum(IV) complex with greater Hsp90 inhibitory activity than cisplatin
Tue Jun 15 00:00:00 EDT 2010
Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts.
BMC cancer
Olsen CJ,Moreira J,Lukanidin EM,Ambartsumian NS
MA1-39540 was used in immunohistochemistry to study the effects of fibroblasts on mammary carcinoma cells.
Thu Aug 19 00:00:00 EDT 2010
Molecular characterization of breast cancer in young Brazilian women.
Revista da Associacao Medica Brasileira (1992)
Carvalho LV,Pereira EM,Frappart L,Boniol M,Bernardo WM,Tarricone V,Tavtigian S,Southey MC
MA1-39540 was used in immunohistochemistry to study the molecular features of breast cancer in young Brazilian women
Fri Aug 26 00:00:00 EDT 2011
Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis.
Medical molecular morphology
Kusafuka K,Itoh H,Sugiyama C,Nakajima T
MA1-39540 was used in immunohistochemistry to report on a case of low grade salivary duct carcinoma.
Wed Sep 01 00:00:00 EDT 2010
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Breast cancer research : BCR
Ma XJ,Dahiya S,Richardson E,Erlander M,Sgroi DC
MA1-39540 was used in immunohistochemistry to profile gene expression in the tumor microenvironment during breast cancer progression using gene microarrays
Tue Jun 23 00:00:00 EDT 2009
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.
Breast cancer research : BCR
Habel LA,Achacoso NS,Haque R,Nekhlyudov L,Fletcher SW,Schnitt SJ,Collins LC,Geiger AM,Puligandla B,Acton L,Quesenberry CP
MA1-39540 was used in immunohistochemistry to study the effect of adjuvant radiotherapy plus tamoxifen on the recurrence of ductal carcinoma
Mon Jul 05 00:00:00 EDT 2010
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy.
Breast cancer research : BCR
Darb-Esfahani S,Loibl S,Müller BM,Roller M,Denkert C,Komor M,Schlüns K,Blohmer JU,Budczies J,Gerber B,Noske A,du Bois A,Weichert W,Jackisch C,Dietel M,Richter K,Kaufmann M,von Minckwitz G
MA1-39540 was used in immunohistochemistry to characterize different breast cancer types using various protein biomarkers
Tue Mar 02 00:00:00 EST 2010
Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles.
Histopathology
Lopes N,Sousa B,Vieira D,Milanezi F,Schmitt F
MA1-39540 was used in immunohistochemistry to study the microvessel features in subtype of breast carcinomas
Sun Nov 01 00:00:00 EDT 2009
Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.
Cancer science
Christgen M,Christgen H,Heil C,Krech T,Länger F,Kreipe H,Lehmann U
MA1-39540 was used in immunohistochemistry to examine the prognostic significance of KAI1/CD82 in estrogen receptor-negative breast cancer
Tue Sep 01 00:00:00 EDT 2009
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
The American journal of surgical pathology
Köbel M,Kalloger SE,Carrick J,Huntsman D,Asad H,Oliva E,Ewanowich CA,Soslow RA,Gilks CB
MA1-39540 was used in immunohistochemistry to examine the diagnostic markers of clear cell and high-grade serous carcinoma of the ovary
Thu Jan 01 00:00:00 EST 2009
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis.
Lung cancer (Amsterdam, Netherlands)
Froio E,D'Adda T,Fellegara G,Martella E,Caruana P,Pruneri G,Pesci A,Rindi G
MA1-39540 was used in immunohistochemistry to report a clinical case of uterine carcinosarcoma with unique features
Mon Jun 01 00:00:00 EDT 2009
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).
Oral oncology
Locati LD,Perrone F,Losa M,Mela M,Casieri P,Orsenigo M,Cortelazzi B,Negri T,Tamborini E,Quattrone P,Bossi P,Rinaldi G,Bergamini C,Calderone RG,Liberatoscioli C,Licitra L
MA1-39540 was used in immunohistochemistry to identify deregulated genes as potential therapeutic targets in salivary gland carcinomas
Sun Nov 01 00:00:00 EDT 2009
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
Breast cancer research and treatment
Brouckaert O,Pintens S,Van Belle V,Van Huffel S,Camerlynck E,Amant F,Leunen K,Smeets A,Berteloot P,Van Limbergen E,Decock J,Hendrickx W,Weltens C,Van den Bogaert W,Vanden Bempt I,Drijkoningen M,Paridaens R,Wildiers H,Vergote I,Christiaens MR,Neven P
MA1-39540 was used in immunohistochemistry to study the short-term prognostic value of hormone and HER-2 receptors in primary operated early breast cancer
Fri May 01 00:00:00 EDT 2009
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Breast cancer research and treatment
Van Calster B,Vanden Bempt I,Drijkoningen M,Pochet N,Cheng J,Van Huffel S,Hendrickx W,Decock J,Huang HJ,Leunen K,Amant F,Berteloot P,Paridaens R,Wildiers H,Van Limbergen E,Weltens C,Timmerman D,Van Gorp T,Smeets A,Van den Bogaert W,Vergote I,Christiaens MR,Neven P
MA1-39540 was used in immunohistochemistry to study axillary lymph node invasion of operable breast cancers and their combined oestrogen receptor, progesterone receptor and HER-2 status
Thu Jan 01 00:00:00 EST 2009
Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer.
Breast cancer research and treatment
Søiland H,Janssen EA,Kørner H,Varhaug JE,Skaland I,Gudlaugsson E,Baak JP,Søreide JA
MA1-39540 was used in immunohistochemistry to study the prognostic value of apoD in women with operable breast cancer
Sun Feb 01 00:00:00 EST 2009
Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Acta oncologica (Stockholm, Sweden)
Søiland H,Skaland I,Varhaug JE,Kørner H,Janssen EA,Gudlaugsson E,Baak JP,Søreide JA
MA1-39540 was used in immunohistochemistry to study the clinical significance of estrogen receptor alpha and Apolipoprotein D co-expression in node positive operable breast cancer
Tue May 12 00:00:00 EDT 2009
Tissue microarray validation: a methodologic study with special reference to lung cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Karlsson C,Bodin L,Piehl-Aulin K,Karlsson MG
MA1-39540 was used in immunohistochemistry to study the validation of tissue microarray analysis with special reference to lung cancer
Wed Jul 01 00:00:00 EDT 2009
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Rejnmark L,Tietze A,Vestergaard P,Buhl L,Lehbrink M,Heickendorff L,Mosekilde L
MA1-39540 was used in immunohistochemistry to investigate the association of prediagnostic plasma 25-hydroxyvitamin D levels with breast cancer risk assessment
Thu Oct 01 00:00:00 EDT 2009
COX-2 expression does not correlate with microvessel density in breast cancer.
Pathobiology : journal of immunopathology, molecular and cellular biology
Thorat MA,Mehrotra S,Morimiya A,Badve S
MA1-39540 was used in immunohistochemistry to study whether COX-2 expression is correlated with microvessel density in breast cancer
Thu Apr 02 00:00:00 EDT 2009
Synchronous presentation of uterine leiomyosarcoma and retroperitoneal liposarcoma: analysis by comparative genomic hybridization and review of the literature.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Chen HK,Huang HY,Li CF,Ko SF,Changchien CC,Chen WJ,Huang CC
MA1-39540 was used in immunohistochemistry to report a clinical case of co-occurrence of uterine leiomyosarcoma and retroperitoneal liposarcoma
Sun Nov 01 00:00:00 EDT 2009
RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Pathology, research and practice
Tezel GG,Uner A,Yildiz I,Guler G,Takahashi M
MA1-39540 was used in immunohistochemistry to investigate the expression of RET finger protein in patients with breast carcinoma
Tue Aug 18 00:00:00 EDT 2009
Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
Cancer prevention research (Philadelphia, Pa.)
Khan SA,Lankes HA,Patil DB,Bryk M,Hou N,Ivancic D,Nayar R,Masood S,Rademaker A
MA1-39540 was used in immunohistochemistry to evaluate ductal lavage as a serial epithelial sampling method for the measurement of breast-specific biomarkers
Sun Mar 01 00:00:00 EST 2009
Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.
Pathology oncology research : POR
Zhou CJ,Zhang QH,Zhang TG,Sun SZ,Li H,Wang Y,Liu ZY
MA1-39540 was used in immunohistochemistry to investigate the expression of estrogen receptor, Ki-67 and cylin D1 in the pre-cancerous breast of Chinese patients
Mon Jun 01 00:00:00 EDT 2009
Evaluation of estrogen treatment in an immunodeficient mouse endometriosis model.
Gynecologic and obstetric investigation
Colette S,Defrère S,Lousse JC,Van Langendonckt A,Loumaye E,Donnez J
MA1-39540 was used in immunohistochemistry to study the effect of estrogen treatment on the development of endometriosis in an immunodeficient mouse model
Thu Feb 25 00:00:00 EST 2010
Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogen.
Cancer prevention research (Philadelphia, Pa.)
Blance RN,Sims AH,Anderson E,Howell A,Clarke RB
MA1-39540 was used in immunohistochemistry to develop a nude mouse model for studying the effect of estrogen on breast tissue
Sun Mar 01 00:00:00 EST 2009
The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.
BMC cancer
Wang L,Jiang Z,Sui M,Shen J,Xu C,Fan W
MA1-39540 was used in immunohistochemistry to evaluate potential biomarkers for the selection of breast cancer treatment regimens
Sat Jul 11 00:00:00 EDT 2009
Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
Diagnostic cytopathology
Hanley KZ,Siddiqui MT,Lawson D,Cohen C,Nassar A
MA1-39540 was used in immunohistochemistry to evaluate multiple monoclonal antibodies for breast cancer studies
Wed Apr 01 00:00:00 EDT 2009
Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in infiltrative breast carcinomas in Indian patients.
Asian Pacific journal of cancer prevention : APJCP
Munjal K,Ambaye A,Evans MF,Mitchell J,Nandedkar S,Cooper K
MA1-39540 was used in immunohistochemistry to characterize the relationship between breast cancer immunohistochemistry and prognosis
Thu May 13 00:00:00 EDT 2010
There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study.
Surgical neurology
Kaya AH,Ulus A,Bayri Y,Topal A,Gun S,Kandemir B,Dagcinar A,Senel A,Iyigun O
MA1-39540 was used in immunohistochemistry to study the absence of estrogen and progesterone receptors in cerebral cavernomas
Tue Sep 01 00:00:00 EDT 2009
Triple negative breast carcinoma is a prognostic factor in Taiwanese women.
BMC cancer
Lin C,Chien SY,Chen LS,Kuo SJ,Chang TW,Chen DR
MA1-39540 was used in western blot to study the prognosis of triple negative breast carcinoma in Taiwanese women
Thu Jun 18 00:00:00 EDT 2009
Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer.
Revista da Associacao Medica Brasileira (1992)
Rocha RM,Nunes CB,Sanches FS,Rocha GF,Oliveira FN,Reis-Filho JS,Lambros MB,Gobbi H
MA1-39540 was used in immunohistochemistry to evaluate novel rabbit monoclonal antibodies for estrogen, progesterone receptors and HER2
Thu May 06 00:00:00 EDT 2010
Cytological criteria to predict basal phenotype of breast carcinomas.
Diagnostic cytopathology
Dufloth RM,Alves JM,Martins D,Vieira DS,Chikota H,Zeferino LC,Schmitt F
MA1-39540 was used in immunohistochemistry to investigate the phenotypic classification of breast cancer based on cytological criteria
Sun Nov 01 00:00:00 EDT 2009
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
De Maeyer L,Van Limbergen E,De Nys K,Moerman P,Pochet N,Hendrickx W,Wildiers H,Paridaens R,Smeets A,Christiaens MR,Vergote I,Leunen K,Amant F,Neven P
MA1-39540 was used in immunohistochemistry to investigate the existence of estrogen receptor negative/progesterone receptor positive breast carcinoma
Thu Jan 10 00:00:00 EST 2008
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Neven P,Brouckaert O,Van Belle V,Vanden Bempt I,Hendrickx W,Cho H,Deraedt K,Van Calster B,Van Huffel S,Moerman P,Amant F,Leunen K,Smeets A,Wildiers H,Paridaens R,Vergote I,Christiaens MR
MA1-39540 was used in immunohistochemistry to study the diagnostic value of the estrogen receptor in early-stage breast cancer
Tue Apr 01 00:00:00 EDT 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research
Cheang MC,Voduc D,Bajdik C,Leung S,McKinney S,Chia SK,Perou CM,Nielsen TO
MA1-39540 was used in immunohistochemistry to define the prognostic markers of basal-like breast cancer
Sat Mar 01 00:00:00 EST 2008
Clinical validation of a customized multiple signature microarray for breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
Tan BK,Tan LK,Yu K,Tan PH,Lee M,Sii LH,Wong CY,Ho GH,Yeo AW,Chow PK,Koong HN,Yong WS,Lim DT,Ooi LL,Soo KC,Tan P
MA1-39540 was used in immunohistochemistry to develop a customized microarray for the clinical classification of breast tumors
Tue Jan 15 00:00:00 EST 2008
Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research
Bartel F,Jung J,Böhnke A,Gradhand E,Zeng K,Thomssen C,Hauptmann S
MA1-39540 was used in immunohistochemistry to study the role of germ line and somatic genetics of the p53 pathway in ovarian cancer incidence and survival
Tue Jan 01 00:00:00 EST 2008
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
Breast cancer research : BCR
Crabb SJ,Bajdik CD,Leung S,Speers CH,Kennecke H,Huntsman DG,Gelmon KA
MA1-39540 was used in immunohistochemistry to identify prognostic biomarkers for breast cancer involving 4 or more auxilliary lymph nodes
Wed Jun 11 00:00:00 EDT 2008
Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Chen MH,Yip GW,Tse GM,Moriya T,Lui PC,Zin ML,Bay BH,Tan PH
MA1-39540 was used in immunohistochemistry to study the correlation between expression of basal cytokeratins and vimentin and adverse pathological parameters in young women with breast cancer
Wed Oct 01 00:00:00 EDT 2008
Prostanoid receptor EP1 expression in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Thorat MA,Morimiya A,Mehrotra S,Konger R,Badve SS
MA1-39540 was used in immunohistochemistry to study the expression of prostanoid receptor EP1 in breast cancer
Tue Jan 01 00:00:00 EST 2008
Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
Histopathology
Kim TH,Huh JH,Lee S,Kang H,Kim GI,An HJ
MA1-39540 was used in immunohistochemistry to study the role of CLDN2 expression in breast cancer development and progression
Tue Jul 01 00:00:00 EDT 2008
Amplified in breast cancer 1 expression in breast cancer.
Histopathology
Thorat MA,Turbin D,Morimiya A,Leung S,Zhang Q,Jeng MH,Huntsman DG,Nakshatri H,Badve S
MA1-39540 was used in immunohistochemistry to study the immunohistochemical expression of AIB1 in breast cancer
Mon Dec 01 00:00:00 EST 2008
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
Breast cancer research and treatment
Turbin DA,Leung S,Cheang MC,Kennecke HA,Montgomery KD,McKinney S,Treaba DO,Boyd N,Goldstein LC,Badve S,Gown AM,van de Rijn M,Nielsen TO,Gilks CB,Huntsman DG
MA1-39540 was used in immunohistochemistry to investigate the expression of estrogen receptor in breast carcinoma through different approaches
Fri Aug 01 00:00:00 EDT 2008
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
Breast cancer research and treatment
Neven P,Van Calster B,Van den Bempt I,Van Huffel S,Van Belle V,Hendrickx W,Decock J,Wildiers H,Paridaens R,Amant F,Leunen K,Berteloot P,Timmerman D,Van Limbergen E,Weltens C,Van den Bogaert W,Smeets A,Vergote I,Christiaens MR,Drijkoningen M
MA1-39540 was used in immunohistochemistry to study the effect of age on steroid and HER-2 receptor expression in operable invasive breast cancer
Tue Jul 01 00:00:00 EDT 2008
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.
Breast cancer research and treatment
Rajput AB,Turbin DA,Cheang MC,Voduc DK,Leung S,Gelmon KA,Gilks CB,Huntsman DG
MA1-39540 was used in immunohistochemistry to study the presence of stromal mast cells as a favourable prognostic marker in invasive breast cancer
Tue Jan 01 00:00:00 EST 2008
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis.
Breast cancer research and treatment
Savage K,Leung S,Todd SK,Brown LA,Jones RL,Robertson D,James M,Parry S,Rodrigues Pinilla SM,Huntsman D,Reis-Filho JS
MA1-39540 was used in immunohistochemistry to study the distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer
Tue Jul 01 00:00:00 EDT 2008
Expression of aromatase and estrogen receptors in human adrenocortical tumors.
Virchows Archiv : an international journal of pathology
Barzon L,Masi G,Pacenti M,Trevisan M,Fallo F,Remo A,Martignoni G,Montanaro D,Pezzi V,Palù G
MA1-39540 was used in immunohistochemistry to investigate the role of aromatase and estrogen in human adrenocortical cancers and the therapeutic significance of antiestrogens and aromatase inhibitors
Fri Feb 01 00:00:00 EST 2008
Parafibromin expression in breast cancer: a novel marker for prognostication?
Journal of clinical pathology
Selvarajan S,Sii LH,Lee A,Yip G,Bay BH,Tan MH,Teh BT,Tan PH
MA1-39540 was used in immunohistochemistry to investigate the usefulness of parafibromin on breast tumor prognosis
Tue Jan 01 00:00:00 EST 2008
Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer.
Acta oncologica (Stockholm, Sweden)
Kim SH,Seo BK,Lee J,Kim SJ,Cho KR,Lee KY,Je BK,Kim HY,Kim YS,Lee JH
MA1-39540 was used in immunohistochemistry to investigate the association between ultrasound and tumor characteristics in breast cancer
Thu Dec 11 00:00:00 EST 2008
The coexistence of invasive ductal carcinoma and malignant phyllodes tumor with liposarcomatous and chondrosarcomatous differentiation in the same breast in a post-osteosarcoma case.
Pathology, research and practice
Kefeli M,Yildiz L,Akpolat I,Balci P,Ozen N
MA1-39540 was used in immunohistochemistry to report on a patient with both invasive ductal carcinoma and malignant phyllodes tumor with liposarcomatous and chondrosarcomatous differentiation
Tue Mar 03 00:00:00 EST 2009
Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Pathology, research and practice
Rocha R,Nunes C,Rocha G,Oliveira F,Sanches F,Gobbi H
MA1-39540 was used in immunohistochemistry to study the high sensitivity of rabbit monoclonal antibodies in estrogen and progesterone receptor immunohistochemistry
Tue Oct 28 00:00:00 EDT 2008
Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
Pathology, research and practice
Kaya H,Bozkurt SU,Erbarut I,Djamgoz MB
MA1-39540 was used in immunohistochemistry to perform immunohistochemical studies of apocrine carcinomas in Turkish women with breast cancer
Thu Aug 21 00:00:00 EDT 2008
Prognostic relevance of androgen receptor detection in operable breast cancer.
Journal of surgical oncology
Søiland H,Kørner H,Skaland I,Janssen EA,Gudlaugsson E,Varhaug JE,Baak JP,Søreide JA
MA1-39540 was used in immunohistochemistry to study the prognostic utility of androgen receptor detection in operable breast cancer
Mon Dec 01 00:00:00 EST 2008
In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients.
BMC cancer
Garvin S,Dabrosin C
MA1-39540 was used in immunohistochemistry to evaluate a microdialysis procedure for the measurement of estradiol and vascular endothelial growth factor in breast tumor
Tue Mar 18 00:00:00 EDT 2008
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research
Badve S,Turbin D,Thorat MA,Morimiya A,Nielsen TO,Perou CM,Dunn S,Huntsman DG,Nakshatri H
MA1-39540 was used in immunohistochemistry to investigate the association between FOXA1 expression and luminal subtype A breast cancer
Wed Aug 01 00:00:00 EDT 2007
Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.
Cancer research
Harrell JC,Dye WW,Harvell DM,Pinto M,Jedlicka P,Sartorius CA,Horwitz KB
MA1-39540 was used in immunohistochemistry to study the lack of estrogen-sensitivity of lymph node metastases in a model of estrogen receptor positive breast cancer
Thu Nov 01 00:00:00 EDT 2007
The contribution of bifunctional SkipDewax pretreatment solution, rabbit monoclonal antibodies, and polymer detection systems in immunohistochemistry.
Archives of pathology & laboratory medicine
Wong SC,Chan JK,Lo ES,Chan AK,Wong MC,Chan CM,Lam MY,Chan AT
MA1-39540 was used in immunohistochemistry to evaluate novel immunohistochemistry reagents and techniques
Sun Jul 01 00:00:00 EDT 2007
Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Carcinogenesis
Ting AY,Kimler BF,Fabian CJ,Petroff BK
MA1-39540 was used in immunohistochemistry to investigate a rat model of concurrent breast and ovarian cancer
Mon Jan 01 00:00:00 EST 2007
A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
Breast cancer research and treatment
Rasmussen LM,Zaveri NT,Stenvang J,Peters RH,Lykkesfeldt AE
MA1-39540 was used in western blot to study a novel dual-acting steroid sulfatase inhibitor and antiestrogen as a breast cancer therapeutic
Sat Dec 01 00:00:00 EST 2007
Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
Virchows Archiv : an international journal of pathology
Tawfik O,Kimler BF,Davis M,Stasik C,Lai SM,Mayo MS,Fan F,Donahue JK,Damjanov I,Thomas P,Connor C,Jewell WR,Smith H,Fabian CJ
MA1-39540 was used in immunohistochemistry to evaluate a novel approach for staging invasive ductal carcinoma of the breast
Fri Jun 01 00:00:00 EDT 2007
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.
Annals of surgical oncology
Wiseman SM,Masoudi H,Niblock P,Turbin D,Rajput A,Hay J,Bugis S,Filipenko D,Huntsman D,Gilks B
MA1-39540 was used in immunohistochemistry to search therapical targets for the treatment of anaplastic thyroid carcinoma
Thu Feb 01 00:00:00 EST 2007
Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina.
The journal of sexual medicine
Traish AM,Kim SW,Stankovic M,Goldstein I,Kim NN
MA1-39540 was used in western blot to study the effect of testosterone on blood flow and the expression of androgen and estrogen receptors in the rat vagina
Tue May 01 00:00:00 EDT 2007
Expression of c-kit proto-oncogene product in breast cancer tissues.
Medical oncology (Northwood, London, England)
Eroğlu A,Sari A
MA1-39540 was used in immunohistochemistry to study the expression of the c-kit proto-oncogene protein in benign and malignant breast tumors
Thu Dec 20 00:00:00 EST 2007
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Disease markers
Decock J,Hendrickx W,Drijkoningen M,Wildiers H,Neven P,Smeets A,Paridaens R
MA1-39540 was used in immunohistochemistry to study the expression of matrix metalloproteinases in luminal A type breast carcinomas
Fri Sep 28 00:00:00 EDT 2007
Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Giordano G,D'Adda T,Gnetti L,Merisio C,Gabrielli M,Melpignano M
MA1-39540 was used in immunohistochemistry to report on a morphological and molecular analysis of two cases of Villoglandular adenocarcinoma of the cervix
Sun Apr 01 00:00:00 EDT 2007
Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Giordano G,D'Adda T,Gnetti L,Merisio C,Raboni S
MA1-39540 was used in immunohistochemistry to report on a case of transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor
Sun Jul 01 00:00:00 EDT 2007
Prognostic factors in Hungarian breast cancer patients.
Anticancer research
Nádasi E,Anga B,Sándor J,Megyesi J,Kelemen D,Mottolese M,Natali PG,Hegedus G,Arany I,Ember I
MA1-39540 was used in immunohistochemistry to study potential prognostic markers in Hungarian breast cancer patients
Thu Mar 29 00:00:00 EDT 2007
Primary neuroendocrine carcinoma of the breast: a case report.
Tumori
Yaren A,Kelten C,Akbulut M,Teke Z,Duzcan E,Erdem E
MA1-39540 was used in immunohistochemistry to report on a case of primary neuroendocrine carcinoma of the breast
Tue Dec 11 00:00:00 EST 2007
Mammary fibroadenoma in a lamb.
Journal of veterinary science
Gulbahar MY,Guvenc T,Yarim M,Kabak YB,Sozgen Y
MA1-39540 was used in immunohistochemistry to report on a case of mammary fibroadenoma in a lamb
Sat Dec 01 00:00:00 EST 2007
The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
International journal of surgical pathology
Ko SS,Na YS,Yoon CS,Park JY,Kim HS,Hur MH,Lee HK,Chun YK,Kang SS,Park BW,Lee JH
MA1-39540 was used in immunohistochemistry to investigate the prognostic value of c-erbB-2 and p53 in axillary lymph node-negative breast cancer
Sun Apr 01 00:00:00 EDT 2007
P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Journal of experimental & clinical cancer research : CR
Naidu R,Har YC,Taib NA
MA1-39540 was used in immunohistochemistry to investigate the influence of P27 V109G mutation on breast cancer metastasis
Thu Mar 01 00:00:00 EST 2007
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Cheang MC,Treaba DO,Speers CH,Olivotto IA,Bajdik CD,Chia SK,Goldstein LC,Gelmon KA,Huntsman D,Gilks CB,Nielsen TO,Gown AM
MA1-39540 was used in immunohistochemistry to study the increased prognostic value of estrogen receptor detection in breast cancer using a novel rabbit monoclonal antibody
Wed Dec 20 00:00:00 EST 2006
Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
Cancer research
Shyamala G,Chou YC,Cardiff RD,Vargis E
MA1-39540 was used in immunohistochemistry to study the effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells
Wed Nov 01 00:00:00 EST 2006
Preoperative and intraoperative diagnosis of low-grade adenosquamous carcinoma of the breast: potential diagnostic pitfalls.
Histopathology
Ho BC,Tan HW,Lee VK,Tan PH
MA1-39540 was used in immunohistochemistry to study pitfalls in the preoperative and intraoperative diagnosis of low-grade adenosquamous carcinoma of the breast
Fri Dec 01 00:00:00 EST 2006
Ovarian metastases of intestinal-type gastric carcinoma: A clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor.
The American journal of surgical pathology
Lerwill MF,Young RH
MA1-39540 was used in immunohistochemistry to report on the clinicopathology of four cases of ovarian metastases of intestinal-type gastric carcinoma
Wed Nov 01 00:00:00 EST 2006
Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy.
Gynecologic oncology
Hwang CS,Park SY,Yu SH,Park JY,Park CT,Han KO
MA1-39540 was used in immunohistochemistry to investigate the transcriptional variants of parathyroid hormone-related peptide gene in hypercalcemia induced by ovarian clear cell carcinoma
Wed Nov 01 00:00:00 EST 2006
Para-testicular cellular angiofibroma: a rare tumour in a male renal transplant patient.
Virchows Archiv : an international journal of pathology
Sabah M,Mohan P,Kay E
MA1-39540 was used in immunohistochemistry to report on a case of para-testicular cellular angiofibroma in a male renal transplant patient
Sun Oct 01 00:00:00 EDT 2006
Estradiol increases VEGF in human breast studied by whole-tissue culture.
Cell and tissue research
Garvin S,Nilsson UW,Huss FR,Kratz G,Dabrosin C
MA1-39540 was used in immunohistochemistry to study the effects of estradiol and progesterone on VEGF expression in human breast studied using whole-tissue culture
Tue Aug 01 00:00:00 EDT 2006
Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Juncker-Jensen A,Lykkesfeldt AE,Worm J,Ralfkiaer U,Espelund U,Jepsen JS
MA1-39540 was used in western blot to study the role of IGFBP-2 as a marker of anti-estrogen-resistant breast cancer cell lines
Tue Aug 01 00:00:00 EDT 2006
Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
Molecular endocrinology (Baltimore, Md.)
Lipfert L,Fisher JE,Wei N,Scafonas A,Su Q,Yudkovitz J,Chen F,Warrier S,Birzin ET,Kim S,Chen HY,Tan Q,Schmidt A,Dininno F,Rohrer SP,Hammond ML,Rodan GA,Freedman LP,Reszka AA
MA1-39540 was used in immunocytochemistry to study antagonist-induced AF2-independent estrogen receptor alpha phosphorylation
Wed Mar 01 00:00:00 EST 2006
Primary squamous cell carcinoma of the endometrium: a case report with immunohistochemical and molecular study.
Gynecologic oncology
Giordano G,D'Adda T,Merisio C,Gnetti L
MA1-39540 was used in immunohistochemistry to report on a case of primary squamous cell carcinoma of the endometrium
Tue Mar 01 00:00:00 EST 2005
Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
The Journal of steroid biochemistry and molecular biology
Sonne-Hansen K,Lykkesfeldt AE
MA1-39540 was used in western blot to study the effect of endogenous aromatization of testosterone on the growth of the human MCF-7 breast cancer cell line
Sat Jan 01 00:00:00 EST 2005
p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.
Virchows Archiv : an international journal of pathology
Matos I,Dufloth R,Alvarenga M,Zeferino LC,Schmitt F
MA1-39540 was used in immunohistochemistry to study the diagnostic markers of basal breast carcinomas
Sat Oct 01 00:00:00 EDT 2005
Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Bhandare D,Nayar R,Bryk M,Hou N,Cohn R,Golewale N,Parker NP,Chatterton RT,Rademaker A,Khan SA
MA1-39540 was used in immunohistochemistry to identify endocrine biomarkers in epithelial cells for breast cancer through ductal lavage
Tue Nov 01 00:00:00 EST 2005
The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen.
Differentiation; research in biological diversity
Kurita T,Medina R,Schabel AB,Young P,Gama P,Parekh TV,Brody J,Cunha GR,Osteen KG,Bruner-Tran KL,Gold LI
MA1-39540 was used in immunohistochemistry to study the requirement of the AP-1 domain of the estrogen receptor alpha in uterine stromal cells for mouse but not human uterine epithelial estrogen responses
Fri Jul 01 00:00:00 EDT 2005
Mucinous cystic tumor of the pancreas with ovarian-like mesenchymal stroma in a male patient.
Digestive diseases and sciences
Goh BK,Tan YM,Kumarasinghe MP,Ooi LL
MA1-39540 was used in immunohistochemistry to investigate the clinicopathological features of a male mucinous cystic tumor patient with ovarian-like stroma
Tue Nov 01 00:00:00 EST 2005
Synchronous endometrial and cervical tumors in a 26-year-old nullipara: diagnostic modalities updated.
Gynecologic and obstetric investigation
Hascalik S,Celik O,Erdem G,Usta U,Alkan A,Karakas HM,Mizrak B
MA1-39540 was used in immunohistochemistry to evaluate a novel diagnostic approach for synchronous endometrial and cervical tumors
Thu May 25 00:00:00 EDT 2006
A membrane estrogen receptor mediates intracellular calcium release in astrocytes.
Endocrinology
Chaban VV,Lakhter AJ,Micevych P
MA1-39540 was used in western blot to investigate the role of estrogen receptor in calcium signaling in astrocytes
Sun Aug 01 00:00:00 EDT 2004
